Ball pen probe in strongly magnetised RF plasmas

A study of ball pen probes (BPPs) in a rf strongly magnetised plasma is reported for the first time. These probes have been successfully used in fusion plasmas, with magnetic fields up to 2.5 T, to measure the plasma potential. In this paper experimental results of various ball pen designs (2 and 4 mm diameter with flat and conical collectors) are presented up to 0.5 T in a low pressure capacitively coupled rf plasma. A theory of the BPP is developed, showing that the increase of the collector potential and plateau region, with collector retraction, requires the electron current to decrease faster than the ion current. Experimentally, it is found that to develop effective electron screening the electron Larmor radius should be smaller than the tunnel internal diameter. Smaller tunnels improve screening due to the tunnel entrance wall sheaths. Inside the tunnel a plateau region forms at 81 mT reducing to a broad peak at higher field strengths. Ion shielding and surface losses (for small tunnel diameters) reduce the collector peak width and maximum potential with increasing magnetic field. Conical collectors were found to increase the length of the plateau region and broaden the peak. Particle in cell simulations were in good agreement with the experimental results. The electron shielding and plateau regions were reproduced but not the broad peak at higher field strengths. Good agreement between both 2 mm BPPs and an emissive probe was found only at 81 mT to within 3 V or 1.3 electron temperatures (T e). For all BPPs at higher field strengths (≥ 250 mT) the maximum collector potential underestimated the emissive probe by more than 2.7 T e (7 V). At these field strengths all BPPs agree with each other to within 1.5 T e (4.1 V). Possible reasons for these disagreements are discussed

A prenylated dsRNA sensor protects against severe COVID-19

Inherited genetic factors can influence the severity of COVID-19, but the molecular explanation underpinning a genetic association is often unclear. Intracellular antiviral defenses can inhibit the replication of viruses and reduce disease severity. To better understand the antiviral defenses relevant to COVID-19, we used interferon-stimulated gene (ISG) expression screening to reveal that OAS1, through RNase L, potently inhibits SARS-CoV-2. We show that a common splice-acceptor SNP (Rs10774671) governs whether people express prenylated OAS1 isoforms that are membrane-associated and sense specific regions of SARS-CoV-2 RNAs, or only express cytosolic, nonprenylated OAS1 that does not efficiently detect SARS-CoV-2. Importantly, in hospitalized patients, expression of prenylated OAS1 was associated with protection from severe COVID-19, suggesting this antiviral defense is a major component of a protective antiviral response

Evaluation of prognostic risk models for postoperative pulmonary complications in adult patients undergoing major abdominal surgery: a systematic review and international external validation cohort study

Background Stratifying risk of postoperative pulmonary complications after major abdominal surgery allows clinicians to modify risk through targeted interventions and enhanced monitoring. In this study, we aimed to identify and validate prognostic models against a new consensus definition of postoperative pulmonary complications. Methods We did a systematic review and international external validation cohort study. The systematic review was done in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We searched MEDLINE and Embase on March 1, 2020, for articles published in English that reported on risk prediction models for postoperative pulmonary complications following abdominal surgery. External validation of existing models was done within a prospective international cohort study of adult patients (≥18 years) undergoing major abdominal surgery. Data were collected between Jan 1, 2019, and April 30, 2019, in the UK, Ireland, and Australia. Discriminative ability and prognostic accuracy summary statistics were compared between models for the 30-day postoperative pulmonary complication rate as defined by the Standardised Endpoints in Perioperative Medicine Core Outcome Measures in Perioperative and Anaesthetic Care (StEP-COMPAC). Model performance was compared using the area under the receiver operating characteristic curve (AUROCC). Findings In total, we identified 2903 records from our literature search; of which, 2514 (86·6%) unique records were screened, 121 (4·8%) of 2514 full texts were assessed for eligibility, and 29 unique prognostic models were identified. Nine (31·0%) of 29 models had score development reported only, 19 (65·5%) had undergone internal validation, and only four (13·8%) had been externally validated. Data to validate six eligible models were collected in the international external validation cohort study. Data from 11 591 patients were available, with an overall postoperative pulmonary complication rate of 7·8% (n=903). None of the six models showed good discrimination (defined as AUROCC ≥0·70) for identifying postoperative pulmonary complications, with the Assess Respiratory Risk in Surgical Patients in Catalonia score showing the best discrimination (AUROCC 0·700 [95% CI 0·683–0·717]). Interpretation In the pre-COVID-19 pandemic data, variability in the risk of pulmonary complications (StEP-COMPAC definition) following major abdominal surgery was poorly described by existing prognostication tools. To improve surgical safety during the COVID-19 pandemic recovery and beyond, novel risk stratification tools are required. Funding British Journal of Surgery Society